Latest Articles
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram
Published: Feb. 11, 2026, 3:33 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India
Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade
Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE
Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18
Published: Feb. 10, 2026, 6:11 a.m.
Endometriosis Treatment Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By FMI - industrytoday.co.uk
Endometriosis Treatment Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By FMI industrytoday.co.uk
Published: Feb. 9, 2026, 10:44 a.m.
Ionic liquid-coated gold core polymeric nanoparticles for selective neutrophil hitchhiking towards endometriosis treatment - Nature
Ionic liquid-coated gold core polymeric nanoparticles for selective neutrophil hitchhiking towards endometriosis treatment Nature
Published: Feb. 5, 2026, 6:20 p.m.
Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies - Il Sole 24 ORE
Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies Il Sole 24 ORE
Published: Feb. 5, 2026, 10:31 a.m.
Joondalup Health Campus joins global cancer treatment trial - PerthNow
Joondalup Health Campus joins global cancer treatment trial PerthNow
Published: Feb. 4, 2026, 6 p.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace
Published: Feb. 4, 2026, 4:47 a.m.
Link copied to clipboard!